Arrowhead Pharmaceuticals Faces Distribution Risks With Vanscoy Reliance
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies
Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup
Express News | Arrowhead Pharmaceuticals Shares up 6.2% ; at Least Two Brokerages Raise PT After Licensing Deal With Sarepta
Arrowhead Pharmaceuticals Shares Are Trading Higher. Chardan Capital Maintained a Buy Rating on the Stock.
